1. Home
  2. ICFI vs PRCT Comparison

ICFI vs PRCT Comparison

Compare ICFI & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ICF International Inc.

ICFI

ICF International Inc.

HOLD

Current Price

$65.79

Market Cap

1.8B

ML Signal

HOLD

Logo PROCEPT BioRobotics Corporation

PRCT

PROCEPT BioRobotics Corporation

HOLD

Current Price

$25.00

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ICFI
PRCT
Founded
1969
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.5B
IPO Year
2006
2021

Fundamental Metrics

Financial Performance
Metric
ICFI
PRCT
Price
$65.79
$25.00
Analyst Decision
Buy
Buy
Analyst Count
4
11
Target Price
$99.25
$35.44
AVG Volume (30 Days)
259.3K
2.0M
Earning Date
04-30-2026
04-23-2026
Dividend Yield
0.85%
N/A
EPS Growth
N/A
1.71
EPS
4.95
N/A
Revenue
$1,229,162,000.00
$308,054,000.00
Revenue This Year
$4.12
$31.62
Revenue Next Year
$5.33
$24.45
P/E Ratio
$13.42
N/A
Revenue Growth
3.72
37.22
52 Week Low
$65.00
$19.35
52 Week High
$101.71
$64.89

Technical Indicators

Market Signals
Indicator
ICFI
PRCT
Relative Strength Index (RSI) 30.32 42.36
Support Level N/A $19.35
Resistance Level $89.69 $29.06
Average True Range (ATR) 2.73 1.51
MACD 0.01 -0.03
Stochastic Oscillator 1.52 20.24

Price Performance

Historical Comparison
ICFI
PRCT

About ICFI ICF International Inc.

ICF International Inc provides professional services and technology-based solutions to government and commercial clients, including management, marketing, technology, and policy consulting and implementation services. Its services support clients that operate in four key markets that include Energy, Environment, Infrastructure and Disaster Recovery; Health and Social Programs and Security and Other Civilian & Commercial. The Company's majority clients are United States federal government departments and agencies. It operates in a single segment, which is providing professional services.

About PRCT PROCEPT BioRobotics Corporation

PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.

Share on Social Networks: